Arrowhead Pharmaceuticals Inc (ARWR) Directors and Executive Officers - CSIMarket
CSIMarket
 
Arrowhead Pharmaceuticals Inc   (NASDAQ: ARWR)

Arrowhead Pharmaceuticals Inc

Officers & Directors


1. Douglas B. Given, M.D. (Chairman): Dr. Given is a healthcare executive with more than 25 years of experience in the biopharmaceutical industry. He is currently the CEO of G Sports Enterprises and has previously served as a CEO or member of the board of directors for several biotech and pharmaceutical companies.

2. Christopher Anzalone, Ph.D. (CEO, President, and Director): Dr. Anzalone has been the CEO of Arrowhead since 2008. Under his leadership, the company has focused on developing RNA interference (RNAi) therapies for a variety of diseases.

3. Victoria Vakiener (Director)

4. Hongbo Lu (Director)

5. William Waddill (Director)

6. Michael S. Perry (Director)

7. Mauro Ferrari (Director)

8. Adeoye Olukotun (Director)

9. Kenneth A. Myszkowski (Chief Financial Officer - Principal Financial and Accounting Officer)

10. Douglass Given (Director, Chairman of the Board of Directors)

11. Christopher Anzalone (Chief Executive Officer, President and Director - Principal Executive Officer),

Arrowhead Pharmaceuticals Inc currently has 711 employees.






ARWR Management Effectiveness ARWR Revenue per Employee ARWR Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.